EA201891911A1 - Применение тамоксифена для лечения кистозного фиброза у пациентов обоих полов - Google Patents
Применение тамоксифена для лечения кистозного фиброза у пациентов обоих половInfo
- Publication number
- EA201891911A1 EA201891911A1 EA201891911A EA201891911A EA201891911A1 EA 201891911 A1 EA201891911 A1 EA 201891911A1 EA 201891911 A EA201891911 A EA 201891911A EA 201891911 A EA201891911 A EA 201891911A EA 201891911 A1 EA201891911 A1 EA 201891911A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tamoxifen
- patients
- treatment
- cystic fibrosis
- floors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Описано применение тамоксифена или его фармацевтически приемлемой соли в качестве лекарственного средства с эстрогеннезависимым действием для лечения кистозного фиброза у пациентов обоих полов. Тамоксифен предпочтительно вводят ингаляционным способом.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A002292A ITUA20162292A1 (it) | 2016-04-05 | 2016-04-05 | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi |
PCT/EP2017/057895 WO2017174529A1 (en) | 2016-04-05 | 2017-04-03 | Use of tamoxifen for the treatment of cystic fibrosis in patients of both sexes |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201891911A1 true EA201891911A1 (ru) | 2019-04-30 |
EA036682B1 EA036682B1 (ru) | 2020-12-08 |
Family
ID=56551460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891911A EA036682B1 (ru) | 2016-04-05 | 2017-04-03 | Применение тамоксифена для лечения кистозного фиброза у пациентов обоих полов |
Country Status (13)
Country | Link |
---|---|
US (1) | US11191738B2 (ru) |
EP (1) | EP3439645B1 (ru) |
JP (1) | JP2019510791A (ru) |
CN (1) | CN109310652A (ru) |
CA (1) | CA3018024A1 (ru) |
EA (1) | EA036682B1 (ru) |
ES (1) | ES2951263T3 (ru) |
HR (1) | HRP20231197T1 (ru) |
HU (1) | HUE064521T2 (ru) |
IT (1) | ITUA20162292A1 (ru) |
PL (1) | PL3439645T3 (ru) |
RS (1) | RS64640B1 (ru) |
WO (1) | WO2017174529A1 (ru) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0893121T3 (da) * | 1997-06-27 | 2002-06-17 | Akzo Nobel Nv | Flydende oral medicinopløsning |
WO2009105234A2 (en) * | 2008-02-19 | 2009-08-27 | Combinatorx, Incorporated | Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
WO2012134965A1 (en) | 2011-03-25 | 2012-10-04 | The Trustees Of Columbia University In The City Of New York | Chloride channel and chloride transporter modulators for therapy in smooth muscle diseases |
-
2016
- 2016-04-05 IT ITUA2016A002292A patent/ITUA20162292A1/it unknown
-
2017
- 2017-04-03 JP JP2018552700A patent/JP2019510791A/ja active Pending
- 2017-04-03 HR HRP20231197TT patent/HRP20231197T1/hr unknown
- 2017-04-03 PL PL17715154.5T patent/PL3439645T3/pl unknown
- 2017-04-03 CN CN201780021545.2A patent/CN109310652A/zh active Pending
- 2017-04-03 US US16/089,528 patent/US11191738B2/en active Active
- 2017-04-03 EA EA201891911A patent/EA036682B1/ru unknown
- 2017-04-03 EP EP17715154.5A patent/EP3439645B1/en active Active
- 2017-04-03 WO PCT/EP2017/057895 patent/WO2017174529A1/en active Application Filing
- 2017-04-03 ES ES17715154T patent/ES2951263T3/es active Active
- 2017-04-03 HU HUE17715154A patent/HUE064521T2/hu unknown
- 2017-04-03 CA CA3018024A patent/CA3018024A1/en active Pending
- 2017-04-03 RS RS20230888A patent/RS64640B1/sr unknown
Also Published As
Publication number | Publication date |
---|---|
US11191738B2 (en) | 2021-12-07 |
HRP20231197T1 (hr) | 2024-01-19 |
EP3439645A1 (en) | 2019-02-13 |
HUE064521T2 (hu) | 2024-03-28 |
ES2951263T3 (es) | 2023-10-19 |
ITUA20162292A1 (it) | 2017-10-05 |
JP2019510791A (ja) | 2019-04-18 |
EP3439645B1 (en) | 2023-07-05 |
CA3018024A1 (en) | 2017-10-12 |
WO2017174529A1 (en) | 2017-10-12 |
EP3439645C0 (en) | 2023-07-05 |
PL3439645T3 (pl) | 2023-08-21 |
CN109310652A (zh) | 2019-02-05 |
US20200297667A1 (en) | 2020-09-24 |
RS64640B1 (sr) | 2023-10-31 |
EA036682B1 (ru) | 2020-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
EA201591363A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
CR20180253A (es) | Composiciones terapéuticas para el tratamiento del virus de unmunodeficiencia humana | |
EA201692436A1 (ru) | Медицинское применение | |
EP3141603A4 (en) | Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective | |
PH12016502352A1 (en) | Pharmaceutical composition | |
EA201691789A1 (ru) | Фармацевтические композиции и соли 1,2,4-оксадиазолбензойной кислоты | |
MD3416631T2 (ro) | Agenți terapeutici pentru bolile neurodegenerative | |
TW201613578A (en) | Pharmaceutical combinations | |
NZ729252A (en) | Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof | |
EA201692278A1 (ru) | Комбинации формотерола и будесонида для лечения хобл | |
AR111374A1 (es) | Uso de lik066 en pacientes con insuficiencia cardíaca | |
EA201692298A1 (ru) | Производные карбоксамидов | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
EA201691656A2 (ru) | Терапевтические способы с применением норибогаина и родственных соединений | |
AR103118A1 (es) | Tratamientos médicos basados en anamorelina | |
EA201301168A1 (ru) | Аклидиний для применения при улучшении качества сна у пациентов с респираторными заболеваниями | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
EA201891911A1 (ru) | Применение тамоксифена для лечения кистозного фиброза у пациентов обоих полов | |
AR094063A1 (es) | Uso de aclidinio, composicion farmaceutica y metodo para mejorar la actividad fisica en pacientes respiratorios | |
PH12016501975A1 (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
NZ713490A (en) | Oral suspension for treating eosinophilic esophagitis | |
EA201991866A1 (ru) | Комбинированная терапия |